Contemporary Status of Acute Myocardial Infarction in Korean Patients: Korean Registry of Acute Myocardial Infarction for Regional Cardiocerebrovascular Centers

Kim, Rock Bum; Hwang, Jin Yong; Park, Hyun Woong; Her, Ae Young; Lee, Jang Hoon; Kim, Moo Hyun; Yoon, Chang Hwan; Cho, Jae-Young; Woo, Sung Il; Kim, Yongcheol; Han, Joung-Ho; Choi, Joon Hyouk; Kim, Song-Yi; Choi, Si Wan; Jee, Sung Ju; Lee, Sang Yeub; Won, Ki‐Bum; Park, Kyeong Soo; Hyun, Dae Woo

doi:10.3390/jcm10030498

Cited by 11 publications

(15 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In the KRAMI data, the in-hospital mortality rate was 5.7% in 2019, whereas the 3-month mortality rate (including in-hospital deaths) was 7.3%. The mortality rate within 1 year including in-hospital mortality was 9.2% [10]. This is presumably because the KRAMI data include more patients who die in the acute stage.…”

Section: E P U B a H E A D O F P R I N Tmentioning

confidence: 96%

“…Currently, patient registration data for South Korea are collected by the Korea Acute Myocardial Infarction Registry (KAMIR) managed by the Myocardial Infarction Research Association [9] and the Korean Registry of Acute Myocardial Infarction (KRAMI) managed by the Regional Cardiocerebrovascular Disease Centers [10], in addition to the National Emergency Department Information Network (NEDIS) [11], which provides emergency room treatment data for patients with myocardial infarction who present to the National Emergency Medical Center. KAMIR and KRAMI are registris conducted by cardiologists, and include accurate diagnosis and treatment information for patients with myocardial infarction, and follow-up information up to 1 year after discharge.…”

Section: E P U B a H E A D O F P R I N Tmentioning

confidence: 99%

“…However, since the data in the registries is not easily accessible, the characteristics of myocardial infarction patients in other countries can be confirmed through published articles. Based on Kim et al article [10], we reviewed the in-hospital and 1-year mortality proportions of myocardial infarction patients from the registries in Japan…”

Section: Sources For Registries Of Other Countriesmentioning

confidence: 99%

“…In the KAMIR data, the median time from symptom onset to treatment in patients diagnosed with myocardial infarction was 189 minutes in 2018, which represents a marked decrease from 257 minutes in 200816). KRAMI calculates the median time from symptom onset to hospital arrival, which was 153 minutes for all patients in 2019 (119 minutes for STEMI, 196 minutes for NSTEMI) [10].…”

Section: Time From Symptom Onset To Hospital Arrival/treatmentmentioning

confidence: 99%

See 3 more Smart Citations

Epidemiology of myocardial infarction in Korea: hospitalization incidence, prevalence, and mortality

Kim

Hwang

2022

Epidemiol Health

Self Cite

View full text Add to dashboard Cite

Objectives and Methods: There were few studies that comprehensively presented epidemiologic indicators of myocardial infarction on Korea. However, some published articles and opened secondary data for myocardial infarction's epidemiology are now available, making it possible to present these indicators. This review provided on the hospitalized incidence, prevalence, and mortality for myocardial infarction on Korea by using articles and opened data such as data of Health Insurance Service, Department of Statistics, survey from sampled population, registry of patients and etc. Also, this review compared several high-income countries epidemiologic indicators of myocardial infarction. Results:The hospitalized incidence of myocardial infarction in Korea was estimated to be 43.2 per 100,000 populations in 2016 and has been increasing since 2011. It was 2.4 times higher in male than female. The prevalence in adults over 30 years was estimated to range from 0.34% to 0.70% in 2020, and this was higher among male and the older. The mortality was 19.3 per 100,000 populations in 2020, showing no significant change or a slight decrease in recent years, and the male mortality was higher than that of females. From the representative inpatients registry data, the proportion of ST elevated myocardial infarction decreased until recently, and the symptom onset to hospital arrival median time was about 2 hours 30 minutes. Conclusions:The epidemiologic indicators of myocardial infarction from a variety of Korean databases showed that the incidence, prevalence, and mortality tend to be lower than those of other western countries but an increasing trend. And so, to produce continuous and accurate epidemiologic indicators, comprehensive support and surveillance system are needed at the national level.

show abstract

Section: E P U B a H E A D O F P R I N Tmentioning

confidence: 96%

Section: E P U B a H E A D O F P R I N Tmentioning

confidence: 99%

Section: Sources For Registries Of Other Countriesmentioning

confidence: 99%

Section: Time From Symptom Onset To Hospital Arrival/treatmentmentioning

confidence: 99%

See 2 more Smart Citations

Epidemiology of myocardial infarction in Korea: hospitalization incidence, prevalence, and mortality

Kim

Hwang

2022

Epidemiol Health

Self Cite

View full text Add to dashboard Cite

show abstract

“…Chest pain is the second most common cause of patient visits to emergency department (ED) and they result in approximately $12 billion in costs in the United States [1,2]. Recent epidemiologic study in Korea also showed that above 11,000 adult patients were diagnosed acute myocardial infarction (AMI) during 3 years [3]. On arrival in the ED, patients with acute chest pain typically undergo electrocardiograms (EKG) and cardiac enzyme determination to rule-in or rule-out acute coronary syndrome (ACS) [4,5].…”

Section: Introductionmentioning

confidence: 99%

Use of Coronary CT Angiography to Predict Obstructive Lesions in Patients with Chest Pain without Enzyme and ST-Segment Elevation

Kim

Shin

et al. 2021

JCM

View full text Add to dashboard Cite

It is challenging to rule out acute coronary syndrome among chest pain patients without both ST-segment elevation in electrocardiography and troponin elevation at emergency departments (ED). The purpose of this study was to develop a prediction model for rapidly determining the occurrence of significant stenosis in coronary computed tomography angiography (CCTA). Retrospective observational cohort study was conducted with 904 patients who had presented with chest pain without troponin elevation and ST-segment changes and underwent CCTA between January 2017 and December 2018. The primary endpoint was the presence of significant stenosis on CCTA, defined as narrowing above 70% diameter. The logistic regression model was used for development a new predictive model. One hundred and thirty-four patients (14.8%) were shown severe stenosis. The independent associated factors for significant stenosis were age ≥65 years, male, diabetes, history of acute coronary syndrome, and typical chest pain. Based these results, we developed a new prediction model. The area under the curve was 0.782 (95% confidence interval 0.742–0.822). Moreover, score of ≥5 was chosen as cut-off values with 86.6% sensitivity and 56.4% specificity. In conclusion, among chest pain patients without ST changes and troponin elevation, the new score will be helpful to identify potential candidate for CCTA such as patients with significant stenosis.

show abstract

Identification and Mapping Real-World Data Sources for Heart Failure, Acute Coronary Syndrome, and Atrial Fibrillation

Studer¹,

Sartini

Suzart-Woischnik³

et al. 2021

Cardiology

View full text Add to dashboard Cite

Background: Transparent and robust real-world evidence sources are increasingly important for global health, including cardiovascular (CV) diseases. We aimed to identify global real-world data (RWD) sources for heart failure (HF), acute coronary syndrome (ACS), and atrial fibrillation (AF). Methods: We conducted a systematic review of publications with RWD pertaining to HF, ACS, and AF (2010–2018), generating a list of unique data sources. Metadata were extracted based on the source type (e.g., electronic health records, genomics, and clinical data), study design, population size, clinical characteristics, follow-up duration, outcomes, and assessment of data availability for future studies and linkage. Results: Overall, 11,889 publications were retrieved for HF, 10,729 for ACS, and 6,262 for AF. From these, 322 (HF), 287 (ACS), and 220 (AF) data sources were selected for detailed review. The majority of data sources had near complete data on demographic variables (HF: 94%, ACS: 99%, and AF: 100%) and considerable data on comorbidities (HF: 77%, ACS: 93%, and AF: 97%). The least reported data categories were drug codes (HF, ACS, and AF: 10%) and caregiver involvement (HF: 6%, ACS: 1%, and AF: 1%). Only a minority of data sources provided information on access to data for other researchers (11%) or whether data could be linked to other data sources to maximize clinical impact (20%). The list and metadata for the RWD sources are publicly available at www.escardio.org/bigdata. Conclusions: This review has created a comprehensive resource of CV data sources, providing new avenues to improve future real-world research and to achieve better patient outcomes.

show abstract

Contemporary Status of Acute Myocardial Infarction in Korean Patients: Korean Registry of Acute Myocardial Infarction for Regional Cardiocerebrovascular Centers

Cited by 11 publications

References 23 publications

Epidemiology of myocardial infarction in Korea: hospitalization incidence, prevalence, and mortality

Epidemiology of myocardial infarction in Korea: hospitalization incidence, prevalence, and mortality

Use of Coronary CT Angiography to Predict Obstructive Lesions in Patients with Chest Pain without Enzyme and ST-Segment Elevation

Identification and Mapping Real-World Data Sources for Heart Failure, Acute Coronary Syndrome, and Atrial Fibrillation

Contact Info

Product

Resources

About